{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2021", "item": "https://www.patentleaderboard.com/2021/"}, {"@type": "ListItem", "position": 3, "name": "Theravance", "item": "https://www.patentleaderboard.com/2021/company/theravance"}, {"@type": "ListItem", "position": 4, "name": "Daniel D. Long", "item": "https://www.patentleaderboard.com/2021/inventor/fl:da_ln:long-4"}]}

Home › 2021 › Theravance › Daniel D. Long

Daniel D. Long — 3 Patents in 2021

TITheravance Biopharma R&D Ip: 3 patents #7 of 39Top 20%

San Francisco, CA: #809 of 7,035 inventorsTop 15%

California: #8,414 of 66,859 inventorsTop 15%

Overall (2021): #86,024 of 548,734Top 20%

3 Patents 2021

Issued Patents 2021

Showing 1–3 of 3 patents

Patent #	Title	Co-Inventors	Date
11155549	Ester and carbonate pyrimidine compounds as JAK kinase inhibitors	Philip A. Gerken, Jianhua Chao	2021-10-26
10961267	Prodrugs of a JAK inhibitor compound for treatment of gastrointestinal inflammatory disease	Ryan Hudson, Donna A. A. Wilton, Mandy Loo, Patrick J. Brassil	2021-03-30
10947229	Dimethyl amino azetidine amides as JAK inhibitors	Cameron Smith, Corbin Thompson	2021-03-16

Daniel D. Long — 3 Patents in 2021

Issued Patents 2021

Patent Widget